462PDPostoperative carcinoembryonic antigen (CEA) association with survival and oxaliplatin benefit in stage II colon cancer (CC): Post hoc analysis of the MOSAIC trial. (23rd October 2018) - Auclin, E; Andre, T; Taieb, J; Banzi, M; van Laethem, J-L; Tabernero, J; Hickish, T; de Gramont, A; Vernerey, D